We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Child Biomarkers Linked to BD Parents

By LabMedica International staff writers
Posted on 15 May 2017
Biomarkers have been identified in children of patients with bipolar disorder that suggest that at the molecular level the disorder is linked to the process of apoptosis and related disturbance of mitochondrial function.

Bipolar disorder (BD) is a severe psychiatric disorder characterized by phasic changes of mood and can be associated with progressive structural brain change and cognitive decline. More...
The numbers and sizes of glia and neurons are reduced in several brain areas, suggesting the involvement of apoptosis in the pathophysiology of BD. Since the changes in mitochondrial dynamics are closely related with the early process of apoptosis and the specific processes of apoptosis and mitochondrial dynamics in BD have not been fully elucidated, investigators at the University of Texas Health Science Center at Houston measured the apoptotic pathway and the expression of mitochondrial fission/fusion proteins from BD patients and healthy controls.

To carry out this study, the investigators analyzed peripheral blood mononuclear cells from 18 children and adolescents in three matched groups: bipolar patients, unaffected offspring of bipolar parents, and children of parents with no history of psychiatric disorders. The investigators determined levels of several pro-apoptotic and anti-apoptotic protein factors, as well as the expression of mitochondrial fission/fusion proteins in peripheral blood mononuclear cells (PBMCs).

The results revealed that levels of the anti-apoptotic proteins Bcl-xL, survivin, and Bcl-xL/Bak dimer were significantly decreased, while active caspase-3 protein levels were significantly increased in PBMCs from BD patients. The mitochondrial fusion-related proteins Mfn2 (mitofusin-2) and Opa1 (mitochondrial dynamin like GTPase) were downregulated, while the fission protein Fis1 (mitochondrial fission 1 protein) in PBMCs from BD patients was upregulated in terms of gene expression and protein levels. A significant decrease in citrate synthase activity was also found. Finally, the investigators reported a positive correlation between Mfn2 and Opa1 with mitochondrial content markers, as well as a negative correlation between mitochondrial fission/fusion proteins and apoptotic markers.

"We have known that children of patients with bipolar disorder have a higher risk of developing the illness but the biological mechanisms are largely unknown," said contributing author Dr. Gabriel R. Fries, a post-doctoral research fellow in the psychiatry and behavioral sciences at the University of Texas Health Science Center at Houston. "By analyzing the blood of children of controls and comparing it to children of bipolar patients, we identified several genes or markers that can explain the increased risk. All combine to modulate the response to stress in these children. We know from clinical studies of behavior and the environment that when children are chronically exposed to stressors, they are at a higher risk of developing bipolar disorder. Bipolar parents may struggle because of their disease, leading to higher environmental stress. Their children, because of the genetic markers they have, could be more vulnerable to stress."

The study was published in the May 2, 2017, online edition of the journal Translational Psychiatry.


New
Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.